Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| Drug Name | WNTinib |
| Trade Name | |
| Synonyms | |
| Drug Descriptions |
WNTinib is a multi-kinase inhibitor with activity against KIT, PDGFRA/B, VEGFR1/2, RET, and FLT3, which potentially decreases tumor growth and has selectivity for CTNNB1-mutant tumors (PMID: 37537299). |
| DrugClasses | FLT3 Inhibitor 69 KIT Inhibitor 57 PDGFR Inhibitor (Pan) 30 RET Inhibitor 53 VEGFR1 Inhibitor 6 VEGFR2 Inhibitor 37 |
| CAS Registry Number | NA |
| NCIT ID | NA |
| Therapy Name | Drugs | Efficacy Evidence | Clinical Trials |
|---|---|---|---|
| WNTinib | WNTinib | 12 | 0 |